Robert Doyle is a Professor of Chemistry at Syracuse University, New York, United States. He has an immense interest in drug development for the treatment of obesity and type 2 diabetes. I have a broad background in synthetic chemistry, drug delivery and protein biochemistry. Of particular relevance to this proposal I worked, as an RSC postdoctoral fellow at the Australian National University (2002-2003), on vitamin B12 (B12) small molecule conjugates for drug delivery.
Medicinal chemistry, Target validation, Biochemistry.